Evidence map›Paper›PMID 32997578›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Reply to L. C. Mendez et al and M. A. Kollmeier et al.

William C Jackson, Holly E Hartman, Robert T Dess, Daniel E Spratt

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

William C JacksonWilliam C. Jackson, MD; Holly E. Hartman, MS; Robert T. Dess, MD; and Daniel E. Spratt, MD, University of Michigan, Ann Arbor, MI.
Holly E HartmanWilliam C. Jackson, MD; Holly E. Hartman, MS; Robert T. Dess, MD; and Daniel E. Spratt, MD, University of Michigan, Ann Arbor, MI.
Robert T DessWilliam C. Jackson, MD; Holly E. Hartman, MS; Robert T. Dess, MD; and Daniel E. Spratt, MD, University of Michigan, Ann Arbor, MI.
Daniel E SprattWilliam C. Jackson, MD; Holly E. Hartman, MS; Robert T. Dess, MD; and Daniel E. Spratt, MD, University of Michigan, Ann Arbor, MI.

Funding

Tissue/InformaticsP50CA186786 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Timothy Dess · 2014 to 2026
$27.6M
Biostatistics Training Program in Cancer ResearchT32CA083654 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Veerabhadran Baladandayuthapani, Kelley McLain Kidwell · 2002 to 2026
$4.3M
NCI NIH HHS P50 CA186786NCI NIH HHS T32 CA083654
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BrachytherapyProstatic NeoplasmsAndrogen AntagonistsAndrogensHumansMaleNetwork Meta-Analysis as TopicRandomized Controlled Trials as TopicAndrogen AntagonistsAndrogens

Identifiers

PMID32997578
PMCPMC7655022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.